Ajoy Chakrabarti has MSc. in Biochemistry from Carleton University, a PhD in Biochemistry from the University of British Columbia, and an MBA from Cornell University. He has over 25 years of diverse product development experience in both pharmaceutical and biotechnology companies. He joined the Gates Foundation in 2016, working across multiple polio vaccine programs to provide strategic guidance and product development expertise as part of the global effort to eradicate polio. He has led efforts to create Intervention Target Product Profiles for COVID-19 vaccines and therapeutics.
Prior to joining the Foundation, Ajoy spent eight years leading cross-functional development teams working on anthrax therapeutics and vaccines, as well as nerve agent antidotes at Emergent BioSolutions. His experience at the Vaccine Research Center (NIH) and Bristol-Myers Squibb (1999-2008) included working in product development, marketing, portfolio management, decision analysis, and forecasting.